1. Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage
- Author
-
Chuyao Liao, Di Wang, Ying Zhang, Zunjian Zhang, Fengguo Xu, Siyuan Qin, Yuxin Zhang, Danting Li, Yuan Tian, and Jie Chen
- Subjects
CYP1A1, cytochrome P450 1A1 ,PF, PF-04859989 ,MOE, molecular operating environment ,MTT, thiazolyl blue tetrazolium bromide ,Kynurenine pathway ,RPKM, reads per kilobase per million mapped reads ,STAT3, signal transducer and activator of transcription 3 ,KAT, kynurenine aminotransferase ,AHR ,GPR35, G protein-coupled receptor 35 ,HRP, horseradish peroxi-dase ,KA, kynurenic acid ,RIPA, radioimmunoprecipitation ,DMSO, dimethyl sulfoxide ,ECL, enhanced chemiluminescence ,Pharmacology ,DPP-4, dipeptidyl peptidase-4 ,PDE5, phosphodiesterase type-5 ,RT-PCR, real-time polymerase chain reaction ,CPT-11, irinotecan ,AHR, aryl hydrocarbon receptor ,chemistry.chemical_compound ,DSS, dextran sulphate sodium ,Intestinal toxicity ,0302 clinical medicine ,Kynurenic acid ,DRE, dioxin response elements ,CH, CH223191 ,LC–MS, liquid chromatography–mass spectrometry ,IS, internal standard ,VCR, vincristine ,General Pharmacology, Toxicology and Pharmaceutics ,GE, gastric emptying ,IL-6, interleukin-6 ,PDB, protein data bank ,Receptor ,GFP, green fluorescence protein ,MOI, multiplicity of infection ,0303 health sciences ,ESI, electrospray ionization ,IBD, inflammatory bowel disease ,HE, hematoxylin and eosin ,ELISA, enzyme-linked immunosorbent assay ,030220 oncology & carcinogenesis ,IDO1, indoleamine 2,3-dioxygenase 1 ,Original Article ,1-MT, 1-methyl-tryptophan ,DAI, disease activity index ,RPMI 1640, Roswell Park Memorial Institute 1640 ,medicine.symptom ,GPR35 ,medicine.drug ,PMA, phorbol 12-myristate 13-acetate ,Linag, linagliptin ,Trp, tryptophan ,Dens-Cl, N-diethyl-amino naphthalene-1-sulfonyl chloride ,Inflammation ,AG, AG490 ,Linagliptin ,Dns-Cl, N-dimethyl-amino naphthalene-1-sulfonyl chloride ,03 medical and health sciences ,PBS, phosphate buffer saline ,FBS, fetal bovine serum ,Downregulation and upregulation ,GI, gastrointestinal transit ,Vard, vardenafil ,Gradually sensing ,medicine ,030304 developmental biology ,MRM, multiple-reaction monitoring ,lcsh:RM1-950 ,KYN, kynurenine ,BCA, bicinchoninic acid ,lcsh:Therapeutics. Pharmacology ,PMSF, phenylmethylsulfonyl fluoride ,chemistry ,ARNT, aryl hydrocarbon receptor nuclear translocator ,ERK1/2, extracellular regulated protein kinases 1/2 ,LPS, lipopolysaccharides ,BSA, bovine serum albumin ,JAK2, janus kinase 2 ,Homeostasis - Abstract
Intestinal toxicity induced by chemotherapeutics has become an important reason for the interruption of therapy and withdrawal of approved agents. In this study, we demonstrated that chemotherapeutics-induced intestinal damage were commonly characterized by the sharp upregulation of tryptophan (Trp)−kynurenine (KYN)−kynurenic acid (KA) axis metabolism. Mechanistically, chemotherapy-induced intestinal damage triggered the formation of an interleukin-6 (IL-6)−indoleamine 2,3-dioxygenase 1 (IDO1)−aryl hydrocarbon receptor (AHR) positive feedback loop, which accelerated kynurenine pathway metabolism in gut. Besides, AHR and G protein-coupled receptor 35 (GPR35) negative feedback regulates intestinal damage and inflammation to maintain intestinal integrity and homeostasis through gradually sensing kynurenic acid level in gut and macrophage, respectively. Moreover, based on virtual screening and biological verification, vardenafil and linagliptin as GPR35 and AHR agonists respectively were discovered from 2388 approved drugs. Importantly, the results that vardenafil and linagliptin significantly alleviated chemotherapy-induced intestinal toxicity in vivo suggests that chemotherapeutics combined with the two could be a promising therapeutic strategy for cancer patients in clinic. This work highlights GPR35 and AHR as the guardian of kynurenine pathway metabolism and core component of defense responses against intestinal damage., Graphical abstract AHR and GPR35 constitute a rationale of defense responses against chemotherapy-induced intestinal damage through gradually sensing Trp–KYN–KA axis metabolism. The formation of IL-6–IDO1–AHR positive feedback loop is driven by AHR through sensing Trp–KYN–KA axis metabolism. AHR and GPR35 sense KA level in a gradient-dependent manner to maintain intestinal integrity and homeostasis.Image 1
- Published
- 2021